Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,422 | 503 | 99.8% |
| Education | $12.32 | 2 | 0.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.87 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,570 | 135 | $0 (2024) |
| United Therapeutics Corporation | $937.14 | 33 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $785.62 | 50 | $0 (2024) |
| Grifols USA, LLC | $701.01 | 62 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $537.30 | 27 | $0 (2024) |
| Genentech USA, Inc. | $328.80 | 18 | $0 (2024) |
| Merck Sharp & Dohme LLC | $278.65 | 14 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $270.76 | 15 | $0 (2023) |
| GENZYME CORPORATION | $263.79 | 15 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $218.71 | 13 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $971.33 | 43 | AstraZeneca Pharmaceuticals LP ($135.42) |
| 2023 | $1,217 | 65 | GlaxoSmithKline, LLC. ($178.36) |
| 2022 | $1,006 | 64 | Grifols USA, LLC ($175.91) |
| 2021 | $850.91 | 55 | United Therapeutics Corporation ($208.82) |
| 2020 | $483.67 | 33 | GlaxoSmithKline, LLC. ($166.80) |
| 2019 | $1,316 | 93 | GlaxoSmithKline, LLC. ($295.08) |
| 2018 | $1,077 | 73 | GlaxoSmithKline, LLC. ($303.61) |
| 2017 | $1,514 | 83 | United Therapeutics Corporation ($360.74) |
All Payment Transactions
509 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $33.32 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Cardiology | ||||||
| 11/21/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Pulmonology | ||||||
| 11/15/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $77.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: NEUROLOGY | ||||||
| 09/24/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Inflammation | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $34.00 | General |
| Category: Respiratory | ||||||
| 09/16/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 09/05/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Respiratory | ||||||
| 08/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: RESPIRATORY | ||||||
| 08/21/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/20/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $37.52 | General |
| Category: NEUROLOGY | ||||||
| 08/08/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $32.63 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/06/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Respiratory | ||||||
| 07/25/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Cardiology | ||||||
| 07/19/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/20/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Pulmonology | ||||||
| 06/12/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $33.61 | General |
| Category: NEUROLOGY | ||||||
| 06/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Respiratory | ||||||
| 05/30/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $17.15 | General |
| Category: HFCWO | ||||||
| 05/23/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 05/22/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Respiratory | ||||||
| 05/21/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Pulmonology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 934 | 1,303 | $350,911 | $114,522 |
| 2022 | 15 | 722 | 1,039 | $268,584 | $87,620 |
| 2021 | 16 | 809 | 1,138 | $309,271 | $104,670 |
| 2020 | 19 | 779 | 1,101 | $303,464 | $99,891 |
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 2 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 28 | $7,952 | $3,534 | 44.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 25 | 25 | $10,150 | $3,398 | 33.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 27 | 27 | $9,936 | $2,842 | 28.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 47 | 51 | $7,446 | $2,196 | 29.5% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 45 | 49 | $4,704 | $1,623 | 34.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 45 | 48 | $7,344 | $1,432 | 19.5% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 14 | 14 | $5,544 | $899.03 | 16.2% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 27 | 29 | $1,885 | $744.82 | 39.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 19 | 20 | $1,820 | $368.16 | 20.2% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2022 | 15 | 18 | $1,062 | $190.89 | 18.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 26 | 26 | $1,144 | $183.21 | 16.0% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2022 | 12 | 12 | $648.00 | $111.77 | 17.2% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 17 | 17 | $918.00 | $110.35 | 12.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 124 | 240 | $123,600 | $40,827 | 33.0% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 86 | 188 | $48,504 | $16,054 | 33.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 103 | 166 | $42,828 | $15,281 | 35.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 93 | 114 | $17,442 | $7,230 | 41.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 31 | 31 | $12,586 | $5,329 | 42.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 30 | 31 | $8,926 | $4,119 | 46.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 26 | 26 | $9,568 | $2,777 | 29.0% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 60 | 61 | $8,906 | $2,699 | 30.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 14 | 15 | $6,495 | $2,261 | 34.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 15 | 28 | $5,964 | $2,219 | 37.2% |
| 94727 | Determination of lung volumes using gas dilution or washout | Office | 2021 | 55 | 55 | $5,280 | $1,868 | 35.4% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 34 | 34 | $5,202 | $1,093 | 21.0% |
About Dr. Nimeshkumar Mehta, M.D
Dr. Nimeshkumar Mehta, M.D is a Internal Medicine healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/19/2011. The National Provider Identifier (NPI) number assigned to this provider is 1184923930.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nimeshkumar Mehta, M.D has received a total of $8,436 in payments from pharmaceutical and medical device companies, with $971.33 received in 2024. These payments were reported across 509 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($8,422).
As a Medicare-enrolled provider, Mehta has provided services to 3,244 Medicare beneficiaries, totaling 4,581 services with total Medicare billing of $406,702. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Salem, OR
- Active Since 03/19/2011
- Last Updated 02/15/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1184923930
Products in Payments
- NUCALA (Biological) $727.24
- Prolastin-C Liquid (Biological) $662.59
- ORENITRAM (Drug) $504.64
- TRELEGY ELLIPTA (Drug) $480.43
- DUPIXENT (Biological) $391.87
- TYVASO (Drug) $374.50
- UPTRAVI (Drug) $307.77
- SYMBICORT (Drug) $296.65
- Xolair (Biological) $249.72
- Arikayce (Drug) $216.64
- Adempas (Drug) $176.30
- XYWAV (Drug) $166.60
- GLASSIA (Biological) $158.26
- BREZTRI (Drug) $156.04
- TUDORZA PRESSAIR (Drug) $153.88
- ANORO (Drug) $149.98
- BREO (Drug) $144.11
- OFEV (Drug) $141.49
- TEZSPIRE (Biological) $134.68
- OPSUMIT (Drug) $131.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Salem
Dr. Michael Katcher, Md, MD
Internal Medicine — Payments: $124,347
Jonh Pineda-Bonilla, Md, MD
Internal Medicine — Payments: $51,042
Dr. Garry Miller, D.o, D.O
Internal Medicine — Payments: $17,070
David Bennion, Md, MD
Internal Medicine — Payments: $13,939
Mr. Gautam Jha, Md, MD
Internal Medicine — Payments: $11,191
Dr. Troy Lunceford, Md, MD
Internal Medicine — Payments: $10,868